Protagonist Therapeutics ...
(PTGX)
undefined
undefined%
At close: undefined
41.08
-0.17%
After-hours Dec 13, 2024, 04:15 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -78.95M | -127.39M | -125.55M | -66.15M | -77.19M | -38.92M | -36.96M | -37.18M | -14.86M | -11.07M |
| Depreciation & Amortization | 3.31M | 3.37M | 2.77M | 2.56M | 2.50M | 527.00K | 406.00K | 317.00K | 247.00K | 258.00K |
| Stock-Based Compensation | 29.29M | 24.20M | 16.39M | 7.90M | 8.35M | 6.92M | 4.24M | 2.13M | 99.00K | 42.00K |
| Other Working Capital | -16.64M | -9.81M | -1.92M | -19.32M | 29.14M | -23.53M | 31.75M | 3.00K | -846.00K | 1.08M |
| Other Non-Cash Items | -4.38M | -549.00K | 1.83M | 781.00K | -557.00K | 206.00K | 625.00K | 4.72M | 83.00K | 1.77M |
| Deferred Income Tax | - | - | - | 1.44M | -775.00K | -658.00K | - | 151.00K | -8.00K | - |
| Change in Working Capital | -19.51M | -7.77M | -3.31M | -19.02M | 26.14M | -18.02M | 35.56M | -112.00K | 52.00K | 1.26M |
| Operating Cash Flow | -70.24M | -108.14M | -107.86M | -72.48M | -41.53M | -49.95M | 3.87M | -29.97M | -14.38M | -7.74M |
| Capital Expenditures | -609.00K | -795.00K | -1.10M | -471.00K | -967.00K | -486.00K | -666.00K | -379.00K | -399.00K | -299.00K |
| Acquisitions | - | -91.47M | 14.76M | 90.49M | 52.74M | - | - | 32.00K | - | - |
| Purchase of Investments | -191.04M | -214.87M | -286.59M | -280.03M | -166.94M | -71.06M | -39.55M | -73.17M | -7.87M | - |
| Sales Maturities Of Investments | 152.40M | 307.14M | 271.83M | 189.53M | 114.19M | 73.76M | 56.03M | 14.19M | - | - |
| Other Investing Acitivies | - | 91.47M | -14.76M | -90.49M | -52.74M | 2.70M | 16.49M | 32.00K | -7.86M | - |
| Investing Cash Flow | -39.26M | 91.47M | -15.86M | -90.97M | -53.71M | 2.21M | 15.82M | -59.33M | -8.26M | -299.00K |
| Debt Repayment | - | - | - | -10.52M | 9.77M | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 38.38M | 4.29M | 6.09M | 2.79M | 1.78M | 934.00K | 1.01M | 22.66M | 17.42M | 9.00M |
| Financial Cash Flow | 170.48M | 18.84M | 129.92M | 247.63M | 46.04M | 24.11M | 65.55M | 106.31M | 17.42M | 9.00M |
| Net Cash Flow | 60.98M | 2.08M | 6.07M | 84.35M | -49.23M | -23.80M | 85.39M | 17.03M | -5.27M | 864.00K |
| Free Cash Flow | -70.84M | -108.93M | -108.97M | -72.95M | -42.49M | -50.43M | 3.21M | -30.35M | -14.78M | -8.04M |